Notably, elevations in C99 have been shown to contribute to AD pathology (Shen & Kelleher, 2007), causing endosomal dysfunction (Jiang et al, 2010) and hippocampal degeneration (Lauritzen et al, 2012; Pulina et al, 2020). This evidence concerns the gene APP and Alzheimer disease.